Tyra Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tyra Biosciences (TYRA).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

1S.Buy

12Buy

Consensus RatingBuy# Analysts13Avg. Consensus PT$44Upside to Avg. PT+111.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 22, 2026	Oppenheimer	Mazahir Alimohamed	PT Cut	Outperform	$50→$40
Sep 22, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Cut	Buy	$30→$29
Sep 10, 2026	Wedbush	Robert Driscoll	Maintained	Outperform	$53
Sep 10, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Cut	Buy	$45→$30
Sep 4, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$45
Jun 17, 2026	Jones Trading	Matthew Murray	Initiate	Buy	$56
Jun 10, 2026	B of A Securities	Geoff Meacham	PT Raise	Buy	$37→$42
May 19, 2026	Wolfe Research	Kalpit Patel	Initiate	Peer Perform	—
May 14, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$45
Apr 15, 2026	Guggenheim	Brad Canino	Initiate	Buy	$54
Apr 6, 2026	Canaccord Genuity	John Newman	Initiate	Buy	$50
Mar 20, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$42→$56
Feb 24, 2026	Cantor Fitzgerald	Li Watsek	Initiate	Overweight	—
Feb 17, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Raise	Buy	$30→$45
Feb 13, 2026	Wedbush	Robert Driscoll	PT Raise	Outperform	$37→$53
Feb 3, 2026	Oppenheimer	Matthew Biegler	PT Raise	Outperform	$36→$50
Feb 3, 2026	Jefferies	Maury Raycroft	PT Raise	Buy	$32→$43
Jan 28, 2026	Barclays	Eliana Merle	Initiate	Overweight	$59
Jan 23, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$33→$42
Dec 16, 2025	Wedbush	Robert Driscoll	PT Raise	Outperform	$30→$37

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

Oppenheimer analyst Mazahir Alimohamed reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and lowers the price target from $50 to $40.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $30 to $29.

Benzinga Newsdesk

PRO
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $53 price target.

Benzinga Newsdesk

Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday

Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $45 to $30.

Benzinga Newsdesk

Why Is Tyra Biosciences Stock Sinking Wednesday?

Tyra Biosciences stock fell sharply as initial dabogratinib Phase 2 data showed a 57% complete response rate at 60 mg.

Vandana Singh

Tyra Biosciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Tyra Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

PRO
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30

Why Is Tyra Biosciences Stock Sinking Wednesday?

People Also Watch

People Also Watch

Tyra Biosciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Tyra Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROOppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

PROHC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

PROWedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday

PROHC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30

Why Is Tyra Biosciences Stock Sinking Wednesday?

People Also Watch

People Also Watch

PRO
Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

PRO
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30